GlassScriptPhysician profile
Joel M Brink
NPI 1477718666
$9,320.12
in general payments reported to CMS, 2019-2025
13 companies · $8,809 in 2025
The $8,809 reported for 2025 was more than what 96% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.44 · 2020: $140 · 2021: $20.74 · 2022: $28.76 · 2023: $127 · 2024: $115 · 2025: $8,809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $8,767 · Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $8,767.11 |
| Food and Beverage | $283.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $8,914.55 | 2023-2025 | Genius Ai Detection, Securview Diagnostic Workstation, 3dquorum |
| Hologic INC | $118.76 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $65.12 | 2019-2025 | |
| Siemens Medical Solutions USA, INC. | $40.81 | 2024 | Biograph Vision 600 (8 Ring/64 Ct) |
| Blue Earth Diagnostics | $37.09 | 2020-2024 | |
| Amgen INC. | $36.10 | 2019-2020 | |
| Servier Pharmaceuticals LLC | $21.43 | 2025 | |
| Northern X-Ray Company | $17.14 | 2023 | General |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.11 | 2019 | |
| Progenics Pharmaceuticals, INC. | $16.07 | 2023 | Pylarify |
| Novartis Pharmaceuticals Corporation | $13.00 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.53 | 2019 | |
| Kyowa Kirin, INC. | $11.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Brink listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.